an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.
Ticker / NAME | Correlation To CTMX | 1D Price Change % | ||
---|---|---|---|---|
CTMX | 100% | +2.71% | ||
MLEC - CTMX | 42% Loosely correlated | +4.58% | ||
BCAB - CTMX | 40% Loosely correlated | +12.95% | ||
PYXS - CTMX | 39% Loosely correlated | -9.52% | ||
TECH - CTMX | 38% Loosely correlated | +0.32% | ||
CRBU - CTMX | 37% Loosely correlated | +2.02% | ||
More |